Stock Analysis: Eli Lilly, E.L.F. Beauty, and CRH PLC

Eli Lilly Stock Performance

• 📉 Eli Lilly's stock has experienced a significant sell-off, with targets being cut by analysts.
• ⚠️ While some believe the sell-off is overdone, others see the break below $700 as confirmation of a top being knocked out.
• 💡 The company's success ratio in weight loss drugs was 12-13%, below the market's expectation of 15%, leading to disappointment.
• 💊 An oral drug could be revolutionary if successful, but the stock had significant expectations built in.
• 📌 One analyst, who owns the stock, plans to hold onto it but advises against buying into it currently.

E.L.F. Beauty Investment Outlook

• 📈 E.L.F. Beauty was upgraded to 'buy' with a potential 20%+ upside, but this call is met with skepticism.
• 💰 A previous trade involved selling calls against the stock, and the stock was sold at $115 before disappointing earnings.
• 📉 The stock is down 10% after earnings, and while potentially okay under $100, faces intense competition in skincare and makeup.
• 🚫 The company lacks the